These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35476408)

  • 1. Identification of Endoplasmic Reticulum α-Glucosidase I from a Thermophilic Fungus as a Platform for Structure-Guided Antiviral Drug Design.
    Karade SS; Kolesnikov A; Treston AM; Mariuzza RA
    Biochemistry; 2022 May; 61(10):822-832. PubMed ID: 35476408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-Based Design of Potent Iminosugar Inhibitors of Endoplasmic Reticulum α-Glucosidase I with Anti-SARS-CoV-2 Activity.
    Karade SS; Franco EJ; Rojas AC; Hanrahan KC; Kolesnikov A; Yu W; MacKerell AD; Hill DC; Weber DJ; Brown AN; Treston AM; Mariuzza RA
    J Med Chem; 2023 Feb; 66(4):2744-2760. PubMed ID: 36762932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structures of mammalian ER α-glucosidase II capture the binding modes of broad-spectrum iminosugar antivirals.
    Caputo AT; Alonzi DS; Marti L; Reca IB; Kiappes JL; Struwe WB; Cross A; Basu S; Lowe ED; Darlot B; Santino A; Roversi P; Zitzmann N
    Proc Natl Acad Sci U S A; 2016 Aug; 113(32):E4630-8. PubMed ID: 27462106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-Substituted Valiolamine Derivatives as Potent Inhibitors of Endoplasmic Reticulum α-Glucosidases I and II with Antiviral Activity.
    Karade SS; Hill ML; Kiappes JL; Manne R; Aakula B; Zitzmann N; Warfield KL; Treston AM; Mariuzza RA
    J Med Chem; 2021 Dec; 64(24):18010-18024. PubMed ID: 34870992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specificity of Processing α-glucosidase I is guided by the substrate conformation: crystallographic and in silico studies.
    Barker MK; Rose DR
    J Biol Chem; 2013 May; 288(19):13563-74. PubMed ID: 23536181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral therapies targeting host ER alpha-glucosidases: current status and future directions.
    Chang J; Block TM; Guo JT
    Antiviral Res; 2013 Sep; 99(3):251-60. PubMed ID: 23816430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing the antiviral potency of ER α-glucosidase inhibitor IHVR-19029 against hemorrhagic fever viruses in vitro and in vivo.
    Ma J; Zhang X; Soloveva V; Warren T; Guo F; Wu S; Lu H; Guo J; Su Q; Shen H; Solon E; Comunale MA; Mehta A; Guo JT; Bavari S; Du Y; Block TM; Chang J
    Antiviral Res; 2018 Feb; 150():112-122. PubMed ID: 29253498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural Insights into the Broad-Spectrum Antiviral Target Endoplasmic Reticulum Alpha-Glucosidase II.
    Caputo AT; Alonzi DS; Kiappes JL; Struwe WB; Cross A; Basu S; Darlot B; Roversi P; Zitzmann N
    Adv Exp Med Biol; 2018; 1062():265-276. PubMed ID: 29845539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Planta Preliminary Screening of ER Glycoprotein Folding Quality Control (ERQC) Modulators.
    Marti L; Lia A; Reca IB; Roversi P; Santino A; Zitzmann N
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30041423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Endoplasmic Reticulum α-Glucosidase I with a Single-Dose Iminosugar Treatment Protects against Lethal Influenza and Dengue Virus Infections.
    Warfield KL; Alonzi DS; Hill JC; Caputo AT; Roversi P; Kiappes JL; Sheets N; Duchars M; Dwek RA; Biggins J; Barnard D; Shresta S; Treston AM; Zitzmann N
    J Med Chem; 2020 Apr; 63(8):4205-4214. PubMed ID: 32227946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of endoplasmic reticulum glucosidases is required for in vitro and in vivo dengue antiviral activity by the iminosugar UV-4.
    Warfield KL; Plummer EM; Sayce AC; Alonzi DS; Tang W; Tyrrell BE; Hill ML; Caputo AT; Killingbeck SS; Beatty PR; Harris E; Iwaki R; Kinami K; Ide D; Kiappes JL; Kato A; Buck MD; King K; Eddy W; Khaliq M; Sampath A; Treston AM; Dwek RA; Enterlein SG; Miller JL; Zitzmann N; Ramstedt U; Shresta S
    Antiviral Res; 2016 May; 129():93-98. PubMed ID: 26946111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents.
    Zitzmann N; Mehta AS; Carrouée S; Butters TD; Platt FM; McCauley J; Blumberg BS; Dwek RA; Block TM
    Proc Natl Acad Sci U S A; 1999 Oct; 96(21):11878-82. PubMed ID: 10518544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small molecule inhibitors of ER α-glucosidases are active against multiple hemorrhagic fever viruses.
    Chang J; Warren TK; Zhao X; Gill T; Guo F; Wang L; Comunale MA; Du Y; Alonzi DS; Yu W; Ye H; Liu F; Guo JT; Mehta A; Cuconati A; Butters TD; Bavari S; Xu X; Block TM
    Antiviral Res; 2013 Jun; 98(3):432-40. PubMed ID: 23578725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ToP-DNJ, a Selective Inhibitor of Endoplasmic Reticulum α-Glucosidase II Exhibiting Antiflaviviral Activity.
    Kiappes JL; Hill ML; Alonzi DS; Miller JL; Iwaki R; Sayce AC; Caputo AT; Kato A; Zitzmann N
    ACS Chem Biol; 2018 Jan; 13(1):60-65. PubMed ID: 29161006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Endoplasmic Reticulum Alpha-Glycosidases as Potential Targets for Virus Control.
    Pérez-García LA; Martínez-Duncker I; Mora Montes HM
    Curr Protein Pept Sci; 2017; 18(11):1090-1097. PubMed ID: 27526926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing the selectivity of ER α-glucosidase inhibitors.
    O'Keefe S; Roebuck QP; Nakagome I; Hirono S; Kato A; Nash R; High S
    Glycobiology; 2019 Jul; 29(7):530-542. PubMed ID: 30976784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iminosugars Inhibit Dengue Virus Production via Inhibition of ER Alpha-Glucosidases--Not Glycolipid Processing Enzymes.
    Sayce AC; Alonzi DS; Killingbeck SS; Tyrrell BE; Hill ML; Caputo AT; Iwaki R; Kinami K; Ide D; Kiappes JL; Beatty PR; Kato A; Harris E; Dwek RA; Miller JL; Zitzmann N
    PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004524. PubMed ID: 26974655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of selective resistance of influenza A virus in presence of host-targeted antiviral, UV-4B.
    Warfield KL; Schaaf KR; DeWald LE; Spurgers KB; Wang W; Stavale E; Mendenhall M; Shilts MH; Stockwell TB; Barnard DL; Ramstedt U; Das SR
    Sci Rep; 2019 May; 9(1):7484. PubMed ID: 31097731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel imino sugar α-glucosidase inhibitors as antiviral compounds.
    Howe JD; Smith N; Lee MJ; Ardes-Guisot N; Vauzeilles B; Désiré J; Baron A; Blériot Y; Sollogoub M; Alonzi DS; Butters TD
    Bioorg Med Chem; 2013 Aug; 21(16):4831-8. PubMed ID: 23582447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategy for Designing Selective Lysosomal Acid α-Glucosidase Inhibitors: Binding Orientation and Influence on Selectivity.
    Kato A; Nakagome I; Hata M; Nash RJ; Fleet GWJ; Natori Y; Yoshimura Y; Adachi I; Hirono S
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32575625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.